Actinic Keratosis

News Actinic Keratosis

• European Commission authorizes EU-wide marketing and distribution of Biofrontera's Ameluz

  Biofrontera was informed by the European Commission that its product Ameluz® (in development called BF-200 ALA) was approved for distribution throughout the entire EU, Norway, Island and Liechtenstein. Already in October had the responsible "European Medicines Agency" recommended the approval that w more

• The EMA recommends approval of Biofrontera's BF-200 ALA

  The European Medicines Agency (EMA) issued a favourable opinion on Biofrontera's marketing approval application for its new medicinal product BF-200 ALA for the treatment of actinic keratosis. There was no recommendation for a restriction or temporal limitation of the approval. The product will be m more

• Positive review of the European Medicines Agency in the approval process of Biofrontera's BF-200 ALA

  Biofrontera has received a positive interim report of the responsible committee of the European Medicines Agency (EMA) in the ongoing centralized approval process of BF-200 ALA for the treatment of actinic keratosis.The "Committee for Medicinal Products for Human Use (CHMP)" provides applicants on d more

Publications Actinic Keratosis

• Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin

  Nicotinamide (vitamin B3) protects from ultraviolet (UV) radiation-induced carcinogenesis in mice and from UV-induced immunosuppression in mice and humans. Recent double-blinded randomized controlled Phase 2 studies in heavily sun-damaged individuals have shown that oral nicotinamide significantly more

• Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring

  Dermoscopy has become an integrative part of the clinical examination of skin tumors. This is because it significantly improves the early diagnosis of melanoma and non-melanoma skin cancer (NMSC) including basal cell carcinoma and keratinocyte skin cancer compared with the unaided eye. Besides its v more

• In Vivo Diagnosis of Melanoma and Nonmelanoma Skin Cancer Using Oblique Incidence Diffuse Reflectance Spectrometry

  Early detection and treatment of skin cancer can significantly improve patient outcome. However, present standards for diagnosis require biopsy and histopathologic examinations that are relatively invasive, expensive, and difficult for patients with many early-stage lesions. Here, we show an oblique more

Market studies Actinic Keratosis

• Actinic Keratosis – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Actinic Keratosis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Actinic Keratosis, complete with latest updates, and special features on late-sta more

• Actinic Keratosis – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Actinic Keratosis - Pipeline Review, H1 2012', provides an overview of the Actinic Keratosis therapeutic pipeline. This report provides information on the therapeutic development for Actinic Keratosis, complete with latest updates, and special features on lat more

• Actinic Keratosis - Pipeline Review, Q1 2011

  Introduction Global Markets Direct’s, 'Actinic Keratosis - Pipeline Review, Q1 2011', provides an overview of the Actinic Keratosis therapeutic pipeline. This report provides information on the therapeutic development for Actinic Keratosis, complete with latest updates, and special features on late more

Websites Actinic Keratosis